Detalhe da pesquisa
1.
Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer.
Proc Natl Acad Sci U S A
; 121(7): e2311854121, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319971
2.
Subtype-specific circadian clock dysregulation modulates breast cancer biology, invasiveness, and prognosis.
bioRxiv
; 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293090